Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumours of the Uterus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01836484
What this trial is testing

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Who this might be right for
Surgically Staged Endometrial and Cervical CarcinomaCervical Cancer: Invasive Disease, FIGO Stage 1B1 or HigherEndometrial Cancer+3 more
Barts & The London NHS Trust 162
Early research (Phase 1)Study completedNCT00005840
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 35
Not applicableUnknownNCT02512848
What this trial is testing

The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period

Who this might be right for
Endometrial Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableUnknownNCT02822833
What this trial is testing

The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer

Who this might be right for
Endometrial Neoplasm
Ankara University 100
Not applicableUnknownNCT04114968
What this trial is testing

Offering Cervical Cancer Screening to Older Women

Who this might be right for
Uterine Cervical NeoplasmUterine NeoplasmUterine Cervical Disease+1 more
University of Aarhus 20,000
Very early researchStudy completedNCT03018249
What this trial is testing

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaFIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI) 50
Early research (Phase 1)Looking for participantsNCT06307925
What this trial is testing

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
HC Biopharma Inc. 122
Large-scale testing (Phase 3)WithdrawnNCT03699176
What this trial is testing

Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Who this might be right for
Uterine Fibroids
Bayer
Not applicableUnknownNCT06341855
What this trial is testing

Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
The First Hospital of Jilin University 100
Testing effectiveness (Phase 2)UnknownNCT00492778
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Who this might be right for
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationEndometrial Mucinous AdenocarcinomaEndometrial Squamous Cell Carcinoma+5 more
GOG Foundation 165
Large-scale testing (Phase 3)Active Not RecruitingNCT03948789
What this trial is testing

Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy

Who this might be right for
Uterine Fibroids
Krankenhaus Nordwest 127
Testing effectiveness (Phase 2)Study completedNCT01011933
What this trial is testing

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03400826
What this trial is testing

Effects of Simvastatin on Uterine Leiomyoma Size

Who this might be right for
Fibroid UterusFibroid TumorLeiomyoma+2 more
Johns Hopkins University 60
Early research (Phase 1)Study completedNCT01138085
What this trial is testing

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Who this might be right for
Cancer
GlaxoSmithKline 240
Testing effectiveness (Phase 2)Study completedNCT00882258
What this trial is testing

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 144
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Testing effectiveness (Phase 2)Study completedNCT00958334
What this trial is testing

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 65
Not applicableEnded earlyNCT03466034
What this trial is testing

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Who this might be right for
Endometrial Cancer
Institute of Cancer Research, United Kingdom 5
Testing effectiveness (Phase 2)Ended earlyNCT00584909
What this trial is testing

A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus

Who this might be right for
Uterine Cancer
University of Alabama at Birmingham 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164534
What this trial is testing

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Who this might be right for
Uterine Cervical Neoplasm
Tata Memorial Hospital 316
Next Page